3//SEC Filing
Peloton Equity AeroCare SPV I, L.P. 3
Accession 0000899243-21-004946
CIK 0001725255other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:20 PM ET
Size
19.1 KB
Accession
0000899243-21-004946
Insider Transaction Report
Form 3
FERRER CARLOS A
Director
Holdings
- (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (1,033,644 underlying) - 1,108,519(indirect: See Footnote)
Class A Common Stock
- 3,466,826
Class A Common Stock
- 328,260(indirect: See Footnote)
Class A Common Stock
Series C Preferred Stock
→ Class A Common Stock (3,214,007 underlying)- (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (306,087 underlying)
Holdings
- 3,466,826
Class A Common Stock
Series C Preferred Stock
→ Class A Common Stock (3,214,007 underlying)- (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (306,087 underlying) - (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (1,033,644 underlying) - 328,260(indirect: See Footnote)
Class A Common Stock
- 1,108,519(indirect: See Footnote)
Class A Common Stock
Peloton Equity I, L.P.
Director
Holdings
- 3,466,826
Class A Common Stock
- 328,260(indirect: See Footnote)
Class A Common Stock
- 1,108,519(indirect: See Footnote)
Class A Common Stock
Series C Preferred Stock
→ Class A Common Stock (3,214,007 underlying)- (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (306,087 underlying) - (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (1,033,644 underlying)
Peloton Equity GP, LLC
Director
Holdings
- 328,260(indirect: See Footnote)
Class A Common Stock
- 1,108,519(indirect: See Footnote)
Class A Common Stock
Series C Preferred Stock
→ Class A Common Stock (3,214,007 underlying)- (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (306,087 underlying) - (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (1,033,644 underlying) - 3,466,826
Class A Common Stock
Holdings
- 3,466,826
Class A Common Stock
- 328,260(indirect: See Footnote)
Class A Common Stock
- 1,108,519(indirect: See Footnote)
Class A Common Stock
Series C Preferred Stock
→ Class A Common Stock (3,214,007 underlying)- (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (306,087 underlying) - (indirect: See Footnote)
Series C Preferred Stock
→ Class A Common Stock (1,033,644 underlying)
Footnotes (5)
- [F1]On December 1, 2020, the Issuer entered into Agreement and Plan of Merger (the "Merger Agreement") with AH Apollo Merger Sub Inc. ("Merger Sub I"), AH Apollo Merger Sub II Inc. ("Merger Sub II"), Peloton Equity, LLC (the "Stockholder Representative") and AeroCare Holdings, Inc. ("AeroCare"). The effective time of the merger occurred on February 1, 2021, at which time the outstanding shares of the Common Stock and Series C Preferred Stock of AeroCare were converted into the right to receive, among other things, shares of the Issuer's Class A Common Stock and Series C Preferred Stock, respectively, pursuant to the Merger Agreement.
- [F2]Shares held by Peloton Equity AeroCare SPV I, L.P. ("Peloton AeroCare I"). Peloton Equity GP, LLC ("Peloton Equity GP") is the general partner of Peloton AeroCare I. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
- [F3]Shares held by Peloton Equity AeroCare SPV II, L.P. ("Peloton AeroCare II"). Peloton Equity GP is the general partner of Peloton AeroCare II. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
- [F4]Shares held by Peloton Equity I, L.P. ("Peloton Equity I"). Peloton Equity GP is the general partner of Peloton Equity I. Carlos Ferrer and Theodore B. Lundberg are the managing members of Peloton Equity GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
- [F5]Upon approval by the stockholders of the Issuer pursuant to the terms of the Merger Agreement, each share of Series C Preferred Stock will be convertible on a 100-for-one basis into the number of shares of the Issuer's Class A Common Stock shown in Column 3, subject to adjustments as set forth in the Certificate of Designation, Preferences and Rights of Series C Convertible Preferred Stock, Par Value $0.0001, of AdaptHealth Corp. dated as of January 29, 2021. The Series C Preferred Stock has no expiration date.
Documents
Issuer
AdaptHealth Corp.
CIK 0001725255
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001669706
Filing Metadata
- Form type
- 3
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:20 PM ET
- Size
- 19.1 KB